At this time, development of analytical methods, as well as the manufacturing process for the active substance and the product are initiated. Production begins for the preclinical and clinical tests. Output rises steadily through development under increasing quality requirements. The product must be ready for full manufacture before start of phase 3 clinical trials.

Time: 7–10 years, all the way through development.